Vor Bio to Participate in the JMP Securities Hematology and Oncology Summit

Rhea-AI Summary

Vor Bio (VOR) to Participate in Fireside Chat at JMP Securities Hematology and Oncology Summit

CAMBRIDGE, Mass., Nov. 27, 2023 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that it will participate in a fireside chat and host virtual 1x1 investor meetings at the JMP Securities Hematology and Oncology Summit.

JMP Securities Hematology and Oncology Summit
Fireside Chat: Tuesday, December 5, 2023 at 1:30 pm ET
Location: Virtual

About Vor Bio
Vor Bio is a clinical-stage cell and genome engineering company that aims to change the standard of care for patients with blood cancers by engineering hematopoietic stem cells to enable targeted therapies post-transplant. For more information, visit: www.vorbio.com.

Contact:

Media & Investors
Sarah Spencer
+1 857-242-6076
sspencer@vorbio.com

FAQ

What is the latest announcement from Vor Bio (VOR)?

Vor Bio (VOR) will participate in a fireside chat and host virtual 1x1 investor meetings at the JMP Securities Hematology and Oncology Summit.

When and where will the fireside chat take place?

The fireside chat will take place on Tuesday, December 5, 2023, at 1:30 pm ET, and the location is virtual.

What is the ticker symbol for Vor Bio?

The ticker symbol for Vor Bio is VOR.

What is the JMP Securities Hematology and Oncology Summit?

The JMP Securities Hematology and Oncology Summit is a conference where Vor Bio will participate in a fireside chat and host virtual 1x1 investor meetings.

Why is Vor Bio participating in the fireside chat?

Vor Bio is participating in the fireside chat to engage with investors and discuss its developments in cell and genome engineering.

What is the significance of Vor Bio's participation in the summit?

Vor Bio's participation in the summit signifies its active involvement in the hematology and oncology space and its commitment to engaging with the investment community.